Trends & Business
Amarin settles lawsuits with Coromega and Omax Health
May 9th 2019Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has reached a settlement with omega-3 dietary supplement companies The Coromega Company, Inc., and Omax Health, Inc over complaints the drug company filed in October of 2018.
Sponsored content: Vitafoods Europe 2019: Guiding the industry to a more sustainable future
April 30th 2019The three-day event (7-9 May 2019, Palexpo, Geneva) will this year focus on bringing the industry together to discuss key challenges such as sustainable sourcing, and wider trends including free-from, plant-based ingredients, and hemp extracts and CBD.